Differential effects of topical corticosteroid and calcineurin inhibitor on the epidermal tight junction

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Experimental Dermatology

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/exd.12055PMID 23174045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tight junctions and differentiation – a chicken or the egg question?

  2012cited by this paper
• Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids

  2011cited by this paper
• Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.

  2011cited by this paper
• Characterization of tight junctions and their disruption by UVB in human epidermis and cultured keratinocytes.

  2011cited by this paper
• Tight junction defects in patients with atopic dermatitis.

  2011cited by this paper
• Tight junction regulates epidermal calcium ion gradient and differentiation.

  2011cited by this paper
• Tight junctions: is there a role in dermatology?

  2010cited by this paper
• Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.

  2009cited by this paper
• External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers

  2009cited by this paper
• Relationship between expression of tight junction-related molecules and perturbed epidermal barrier function in UVB-irradiated hairless mice

  2008cited by this paper
• Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains.

  2008cited by this paper
• Tight junction proteins in keratinocytes: localization and contribution to barrier function

  2007cited by this paper
• Adverse effects of topical glucocorticosteroids.

  2006cited by this paper
• Discovery of Topical Calcineurin Inhibitors and Pharmacological Profile of Pimecrolimus

  2006cited by this paper
• Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease.

  2004cited by this paper
• Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.

  2003cited by this paper
• Claudin-based tight junctions are crucial for the mammalian epidermal barrier

  2002cited by this paper
• Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis.

  2002cited by this paper
• Organization and formation of the tight junction system in human epidermis and cultured keratinocytes.

  2002cited by this paper
• Complex phenotype of mice lacking occludin, a component of tight junction strands.

  2000cited by this paper

• Short-term effect of a moderate-potency topical corticosteroid on epidermal biophysical parameters in patients with mild-to-moderate atopic dermatitis: A randomised controlled study

  2024cites this paper
• The Role of Tight Junctions in Atopic Dermatitis: A Systematic Review

  2023cites this paper
• Targeting skin barrier function in atopic dermatitis.

  2023cites this paper
• The Effects of Mucopolysaccharide Polysulfate on Steroid-Induced Tight Junction Barrier Dysfunction in Human Epidermal Keratinocytes and a 3D Skin Model

  2023cites this paper
• Topical therapy of atopic dermatitis with a focus on pimecrolimus

  2021cites this paper
• Lithospermum erythrorhizon Alleviates Atopic Dermatitis-like Skin Lesions by Restoring Immune Balance and Skin Barrier Function in 2.4-Dinitrochlorobenzene-Induced NC/Nga Mice

  2021influential citation
• Effects of Delgocitinib Ointment 0.5% on the Normal Mouse Skin and Epidermal Tight Junction Proteins in Comparison With Topical Corticosteroids

  2020cites this paper
• Atopic dermatitis

  2020cites this paper
• Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel.

  2019cites this paper
• Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation.

  2019cites this paper
• Prurigo nodularis as a sweat gland/duct-related disorder: resolution associated with restoration of sweating disturbance

  2019cites this paper
• Skin Barrier Function and Atopic Dermatitis

  2018cites this paper
• Impact of topical anti-inflammatory therapy on morpho-functional characteristics of epidermal barrier. Optimization of atopic dermatitis treatment schedules

  2018cites this paper
• Anti-Inflammatory Effect and Skin Toxicity of Aqueous Extract of Dorema ammoniacum Gum in Experimental Animals

  2018cites this paper
• Влияние наружной противовоспалительной терапии на морфофункциональные характеристики эпидермального барьера. Оптимизация схем лечения атопического дерматита

  2018cites this paper
• Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs.

  2017cites this paper
• Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice.

  2017cites this paper
• Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with β-casein expression in mammary epithelial cells.

  2016cites this paper
• Aerosol Delivery Enhances Percutaneous Permeability of Epidermal Growth Factor and Thioredoxin

  2016cites this paper
• UVB induces epidermal 11β‐hydroxysteroid dehydrogenase type 1 activity in vivo

  2015cites this paper
• The topical corticosteroid classification called into question: towards a new approach

  2015cites this paper
• Estudo da expressão de filagrina e claudinas 1 e 4 em indivíduos adultos com dermatite atópica

  2015cites this paper
• Intestinal barrier function and the brain-gut axis.

  2014cites this paper
• Nanomiemgel - A Novel Drug Delivery System for Topical Application - In Vitro and In Vivo Evaluation

  2014cites this paper
• Wheat germ agglutinin as a counterstain for immunofluorescence studies of equine hoof lamellae

  2014cites this paper
• Therapeutics and Other Interventions

  2014cites this paper
• Atopic dermatitis and skin barrier dysfunction

  2013cites this paper